← Back to patent-cliff list
CAS 124-40-3
dimethylamineN-MethylmethanamineDimethylamineDimethylamine anhydrous
Codes: RIBO-007, Tetracaine-021, SUMAT-007, DESV-002, Desvenlafaxine-012, (XIV)145089-2-a, (XI)145089-4-b, (IV)145089-11-a, (III)145089-21-a
Application context (from source-drug indications)
Breast cancerRibociclib SuccinateAnaesthesiaOxymetazoline Hydrochloride/Tetracaine HydrochloridePeriapical periodontitisOxymetazoline Hydrochloride/Tetracaine HydrochlorideDental cariesOxymetazoline Hydrochloride/Tetracaine HydrochlorideMigraineNaproxen Sodium/Sumatriptan SuccinateMigraine without auraNaproxen Sodium/Sumatriptan SuccinateDepressive disorderDesvenlafaxine Succinate HydrateMajor depressive disorderDesvenlafaxine Succinate HydrateDepressionDesvenlafaxine Succinate HydrateDiabetic neuropathyDesvenlafaxine Succinate HydratePainDesvenlafaxine Succinate HydrateFibromyalgiaDesvenlafaxine Succinate HydrateMajor depressive disorderDesvenlafaxineDepressive disorderDesvenlafaxineAnaesthesiaTetracaine HydrochlorideRetinitis pigmentosaTetracaine HydrochloridePainTetracaine HydrochlorideCluster headacheSumatriptan SuccinateMigraineSumatriptan SuccinateSecondary headache disorderSumatriptan SuccinatePost-traumatic headacheSumatriptan SuccinateAlzheimer's diseaseRivastigmine TartrateDementiaRivastigmine TartrateParkinson's diseaseRivastigmine Tartrate抗胆碱能综合征Rivastigmine Tartrate神经行为学表现Rivastigmine TartrateCognitive impairmentRivastigmine Tartrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Ribociclib Succinate | Tier A — Act now | 2029 |
| Oxymetazoline Hydrochloride/Tetracaine Hydrochloride | Tier C — Watch / trade | - |
| Naproxen Sodium/Sumatriptan Succinate | Tier C — Watch / trade | - |
| Desvenlafaxine Succinate Hydrate | Tier C — Watch / trade | - |
| Desvenlafaxine | Tier C — Watch / trade | - |
| Tetracaine Hydrochloride | Tier C — Watch / trade | - |
| Sumatriptan Succinate | Tier C — Watch / trade | - |
| Rivastigmine Tartrate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
5-bromo-2,4-dichloropyrimidine→cyclopentanamine→5-bromo-2-chloro-N-cyclopentylpyrimidin-4-amine→prop-2-yn-1-ol→3-(2-chloro-4-(cyclopentylamino)pyrimidin-5-yl)prop-2-yn-1-ol→(2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol→dimethylamine→2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide→tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate→tert-butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate→5-chloro-2-nitropyridine→piperazine→1-(6-nitropyridin-3-yl)piperazine→tert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate
4-Aminobenzoic acid sodium salt→4-(Butylamino)benzoic acid→p-Chlorobenzoic acid→4-Bromobenzoic acid→4-Iodobenzoic acid→Butylamine→4-(Butylamino)benzoic acid ethyl ester→2-(Dimethylamino)ethanol hydrochloride→2-Chloroethanol→4-(Butylamino)benzoic acid 2-chloroethyl ester→N-Methylmethanamine→n-Butyl bromide→N,N-Dimethylaminoethanol→4-Aminobenzoic acid 2-(dimethylamino)ethyl ester→4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester
1-(4-aminophenyl)-N-methylmethanesulfonamide→1-(3-hydrazineylphenyl)-N-methylmethanesulfonamide→2-(phenylthio)acetaldehyde→(E)-N-methyl-1-(3-(2-(2-(phenylthio)ethylidene)hydrazineyl)phenyl)methanesulfonamide→N-methyl-1-(3-(phenylthio)-1H-indol-5-yl)methanesulfonamide→1-(1H-indol-5-yl)-N-methylmethanesulfonamide→dimethylamine→N,N-dimethyl-2-(5-((N-methylsulfamoyl)methyl)-1H-indol-3-yl)-2-oxoacetamide→1-(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide
2-(4-Hydroxyphenyl)acetic acid→2-(4-Hydroxyphenyl)acetyl chloride→Dimethylamine→2-(4-Hydroxyphenyl)-N,N-dimethylacetamide→2-[4-[tert-Butyl(dimethyl)silyloxy]phenyl]-N,N-dimethylacetamide→Cyclohexanone→2-[4-[tert-Butyl(dimethyl)silyloxy]phenyl]-2-(1-hydroxycyclohexyl)-N,N-dimethylacetamide→4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol→2-(1-Hydroxycyclohexyl)-2-(4-hydroxyphenyl)-N,N-dimethylacetamide
1-(4-Hydroxyphenyl)ethanone→1-[4-(Benzyloxy)phenyl]ethanone→1-[4-(benzyloxy)phenyl]-2-bromoethan-1-one→Dimethylamine→1-[4-(Benzyloxy)phenyl]-2-(dimethylamino)ethanone hydrobromide→1-[4-(Benzyloxy)phenyl]-2-(dimethylamino)ethanol hydrochloride→2-[4-(Benzyloxy)phenyl]-2-chloro-N,N-dimethylethanamine hydrochloride→Cyclohexanone→1-{1-[4-(Benzyloxy)phenyl]-2-(dimethylamino)ethyl}cyclohexan-1-ol→4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol
4-Aminobenzoic acid sodium salt→4-(Butylamino)benzoic acid→p-Chlorobenzoic acid→4-Bromobenzoic acid→4-Iodobenzoic acid→Butylamine→4-(Butylamino)benzoic acid ethyl ester→2-(Dimethylamino)ethanol hydrochloride→2-Chloroethanol→4-(Butylamino)benzoic acid 2-chloroethyl ester→N-Methylmethanamine→n-Butyl bromide→N,N-Dimethylaminoethanol→4-Aminobenzoic acid 2-(dimethylamino)ethyl ester→4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester
1-(4-aminophenyl)-N-methylmethanesulfonamide→1-(3-hydrazineylphenyl)-N-methylmethanesulfonamide→2-(phenylthio)acetaldehyde→(E)-N-methyl-1-(3-(2-(2-(phenylthio)ethylidene)hydrazineyl)phenyl)methanesulfonamide→N-methyl-1-(3-(phenylthio)-1H-indol-5-yl)methanesulfonamide→1-(1H-indol-5-yl)-N-methylmethanesulfonamide→dimethylamine→N,N-dimethyl-2-(5-((N-methylsulfamoyl)methyl)-1H-indol-3-yl)-2-oxoacetamide→1-(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide
1-(3-Hydroxyphenyl)ethanone→1-(3-Methoxyphenyl)ethanone→(1E)-1-(3-Methoxyphenyl)ethanone oxime→1-(3-Methoxyphenyl)ethanamine→1(S)-(3-Methoxyphenyl)ethylamine 2(S)-hydroxy-2-phenylacetate→1(S)-(3-Methoxyphenyl)-N,N-dimethylethylamine→(-)-3-((1S)-1-(Dimethylamino)ethyl)phenol→Potassium 3-[(1S)-1-(dimethylamino)ethyl]phenolate→N-Ethyl-N-methylcarbamic chloride→Ethyl(methyl)carbamic bromide→(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate→1(R)-(3-Methoxyphenyl)-N,N-dimethylethylamine 2(S)-hydroxy-2-phenylacetate→1(R)-(3-Methoxyphenyl)-N,N-dimethylethylamine→(1R)-1-(3-Methoxyphenyl)ethanol→(1R)-1-(3-Methoxyphenyl)ethyl methanesulfonate→Dimethylamine anhydrous→N-[(1Z)-1-(3-Methoxyphenyl)ethylidene]methanamine→N-Boc-[1(S)-(3-Methoxyphenyl)ethyl]-N-methylamine
1-(3-Hydroxyphenyl)ethanone→3-[1(R)-Hydroxyethyl]phenol→3-[(1R)-1-[(Methanesulfonyl)oxy]ethyl]phenyl methanesulfonate→Dimethylamine anhydrous→3-[(1S)-1-(Dimethylamino)ethyl]phenyl methanesulfonate→(-)-3-((1S)-1-(Dimethylamino)ethyl)phenol→N-Ethyl-N-methylcarbamic chloride→(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate→3-Acetylphenyl ethyl(methyl)carbamate→3-[(1R)-1-Hydroxyethyl]phenyl ethyl(methyl)carbamate→(1R)-1-(3-[[Ethyl(methyl)carbamoyl]oxy]phenyl)ethyl methanesulfonate
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic
acid Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 2-Chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6- carboxamide Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.